Apixaban study for atrial fibrillation
Part of Heart & circulation clinical trials.
This trial tests whether apixaban, a blood thinner, works well for people with atrial fibrillation who also have heart or circulation conditions. It uses a smartphone app to help track your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- You have been diagnosed with atrial fibrillation
- You also have at least one of these: heart failure, high blood pressure, coronary artery disease, peripheral artery disease, diabetes, a history of stroke, or another heart condition needing treatment
- You are currently taking or planning to start the blood thinner apixaban
- You have a smartphone that runs Android
- You are willing and able to give your consent to be in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests apixaban (a blood thinner) to prevent stroke in people with atrial fibrillation or atrial flutter who have very poor kidney function or are on dialysis. If you qualify, you may help researchers find a safer way to lower stroke risk for this higher-risk group.
This study looks at what results from atrial fibrillation ablation (a heart rhythm procedure) and newer related therapies. If you recently had the procedure—or are scheduled for it soon—you may use an app and website to share information that helps researchers compare outcomes and improve care.
This study uses a smartphone app and activity tracker to help people with atrial fibrillation (an irregular heartbeat) and a higher body weight manage their condition through tailored exercise guidance.
This study tests whether using a smartwatch to monitor your heartbeat can safely guide when to take blood thinners. If you have intermittent atrial fibrillation, you may be able to avoid taking blood thinners when your heart rhythm is normal.
This study compares two blood thinners, apixaban and rivaroxaban, to see which is safer and works better for veterans with atrial fibrillation (irregular heartbeat). If you're already taking one of these, the study will assign you to one of them.
This study follows people with atrial fibrillation to see how well blood-thinning medications work and what outcomes they experience over time. It aims to improve treatment guidance for patients with this common heart rhythm condition.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.